Clin Infect Dis. 2018 Oct 11. doi: 10.1093/cid/ciy876. [Epub ahead of print]
Vaccine effectiveness against lineage matched and mismatched influenza B viruses across 8 seasons in Canada, 2010-11 to 2017-18.
Skowronski DM1,2, Chambers C1, De Serres G3,4,5, Sabaiduc S1, Winter AL6, Dickinson JA7, Gubbay JB6,8, Drews SJ9,10, Fonseca K7,11, Charest H3,12, Martineau C3,12, Hickman R1, Chan T1, Jassem A1,2, Petric M2, Rose C1,2, Bastien N13, Li Y13, Krajden M1,2.
Author information
Abstract
Vaccine effectiveness (VE) against influenza B was derived separately for Victoria and Yamagata lineages across eight seasons (2010-11 to 2017-18) in Canada when trivalent influenza vaccine was predominantly used. VE was ≥50% regardless of lineage match to circulating viruses, except when the vaccine strain was unchanged from the prior season.
PMID: 30312364 DOI: 10.1093/cid/ciy876
Vaccine effectiveness against lineage matched and mismatched influenza B viruses across 8 seasons in Canada, 2010-11 to 2017-18.
Skowronski DM1,2, Chambers C1, De Serres G3,4,5, Sabaiduc S1, Winter AL6, Dickinson JA7, Gubbay JB6,8, Drews SJ9,10, Fonseca K7,11, Charest H3,12, Martineau C3,12, Hickman R1, Chan T1, Jassem A1,2, Petric M2, Rose C1,2, Bastien N13, Li Y13, Krajden M1,2.
Author information
Abstract
Vaccine effectiveness (VE) against influenza B was derived separately for Victoria and Yamagata lineages across eight seasons (2010-11 to 2017-18) in Canada when trivalent influenza vaccine was predominantly used. VE was ≥50% regardless of lineage match to circulating viruses, except when the vaccine strain was unchanged from the prior season.
PMID: 30312364 DOI: 10.1093/cid/ciy876